{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:04:29Z","timestamp":1761807869293},"reference-count":17,"publisher":"Mark Allen Group","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Nurs"],"published-print":{"date-parts":[[2007,12,1]]},"abstract":"<jats:p> The insertion of peripheral and central venous access devices carries a high risk of healthcare-associated infection. One of the main risks of this procedure is the introduction of microorganisms from the patient\u2019s own skin. To combat this, and to reduce the rates of healthcare-associated infection, effective skin antisepsis using 2% chlorhexidine gluconate (CHG) in 70% isopropyl alcohol (IPA) has been recommended by the epic2: National Evidence-Based Guidelines for Preventing HealthcareAssociated Infections in NHS Hospitals in England (Pratt et al, 2007). This article discribes the introduction of 2% CHG in 70% IPA into the United Kingdom healthcare market and gives a discussion of the recommendations of epic2 (Pratt et al, 2007). The article identifies the correct use of 2%CHG 70% IPA solution, by detailing the variety of products and applications now available. It also clarifies their correct application and use to enable Trusts to provide a high standard of infection control and reduce healthcare-associated infection. It highlights the potential incorrect use of the available products due to cost pressures within the healthcare setting. <\/jats:p>","DOI":"10.12968\/bjon.2007.16.22.27769","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T14:11:12Z","timestamp":1400854272000},"page":"1390-1394","source":"Crossref","is-referenced-by-count":9,"title":["Skin antisepis: using 2% chlorhexidine gluconate in 70% isopropyl alcohol"],"prefix":"10.12968","volume":"16","author":[{"given":"Sheila","family":"Inwood","sequence":"first","affiliation":[{"name":"Vascular Access Service, North Block, Royal Berkshire NHS Foundation Trust, London Road, Reading, Berkshire"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5130","reference":[{"key":"p_31","volume-title":"to define the","author":"Guidelines Network","year":"2004"},{"key":"p_40","volume-title":"RCN IV Therapy Annual Conference. RCN","author":"Bravery K","year":"2007"},{"key":"p_41","doi-asserted-by":"publisher","DOI":"10.1053\/jhin.2002.1349"},{"issue":"6","key":"p_42","doi-asserted-by":"crossref","first-page":"374","DOI":"10.5694\/j.1326-5377.1994.tb127491.x","volume":"161","author":"Collignon P","year":"1994","journal-title":"Med J Aust"},{"key":"p_43","volume-title":"J Adv Vas Dev Spring: 26-31","author":"Crosby CT","year":"2001"},{"key":"p_44","volume-title":"London","author":"Department of Health","year":"2006"},{"key":"p_45","volume-title":"How You Can Help Us Prevent and Control Infection in Hospitals: Information for patients and visitors","author":"Health Promotion Agency","year":"2006"},{"key":"p_46","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.4.627"},{"key":"p_47","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-6553(88)80005-1"},{"key":"p_48","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199611000-00010"},{"key":"p_49","volume-title":"The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England. Report by the Comptroller and Auditor General.The Stationery Office","author":"National Audit Office","year":"2000"},{"key":"p_50","volume-title":"Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers","author":"National Institute for Health and Clinical Excellence","year":"2005"},{"issue":"4","key":"p_51","first-page":"64","volume":"18","author":"Nunn T","year":"2002","journal-title":"Pharmacy Management"},{"key":"p_52","doi-asserted-by":"publisher","DOI":"10.2307\/30141155"},{"key":"p_53","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-6701(07)60002-4"},{"key":"p_54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2007.06.017"},{"key":"p_55","volume-title":"SIGN 50: A Guideline Developers' Handbook","author":"Scottish Intercollegiate Guidelines Network","year":"2004"}],"container-title":["British Journal of Nursing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/pdf\/10.12968\/bjon.2007.16.22.27769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T20:31:20Z","timestamp":1653337880000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/10.12968\/bjon.2007.16.22.27769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,1]]},"references-count":17,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2007,12,1]]}},"alternative-id":["10.12968\/bjon.2007.16.22.27769"],"URL":"https:\/\/doi.org\/10.12968\/bjon.2007.16.22.27769","relation":{},"ISSN":["0966-0461","2052-2819"],"issn-type":[{"value":"0966-0461","type":"print"},{"value":"2052-2819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,1]]}}}